The 7th Annual Scientific Forum of Clinical Hypertension of the JSH
English session
Prospects on International FJSH
KYOTO Declaration on Hypertension in Asia by the Japanese Society of Hypertension
The current status and challenges of hypertension clinical practice in Asian countries and the expected role for Japan
Opening remarks
Masaaki Ito
May 20 (Sun) 10:40–11:00 Room1
Keynote Lecture
chair: | Sadayoshi Ito | (Div. of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Graduate School of Medicine) |
---|
SPIV–KL | How to solve the problem of High Blood Pressure in ASIA. |
---|
Trefor Morgan
Department of Physiology, University of Melbourne. Australia
5月20日(日) 11:00–12:30 Room1
chair: | Atsuhiro Ichihara | (Department of Endocrinology and Hypertension, Tokyo Women's Medical University) |
---|---|---|
Yusuke Ohya | (University of the Ryukyus School of Medicine) |
SPIV–1 | Anticipation Telemedicine from Disaster Cardiovascular Protection (DCAP) Network |
---|
Kazuomi Kario
Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine
SPIV–2 | The need for an Asian guideline for the management of hypertension |
---|
Ji–Guang Wang
Cardiovascular medicine in Shanghai Jiaotong University School of Medicine/China
SPIV–3 | Current status and problems of hypertension treatment in Korea. What contributions can we expect from Japan to improve our problems? |
---|
Sung–Ha Park
Division of Cardiology Severance Cardiovascular Hospital Yonsei University College of Medicine, Seoul/Korea
SPIV–4 | 15–year trends of hypertension and other cardiovascular risk factors in Vietnam |
---|
Quang Ngoc Nguyen
Department of Cardiology, Hanoi Medical University/Vietnam
SPIV–5 | Perspectives of salt reduction strategy in Japan. |
---|
Takuya Tsuchihashi
Steel Memorial Yawata Hospital
Closing remarks |
---|
Sadayoshi Ito
KYOTO Declaration on Hypertension in Asia
Yusuke Ohya
Introduction of “iFJSH”